RNATx Inclusivity Grant Application

To support the exploration of RNA therapeutics research to those trainees and early career researchers whom are underrepresented* in the scientific community, we will offer awards to graduate students, post-doctoral researchers, and young investigators (within their first 3 years). The grants will provide reimbursement of the cost of registration or a registration waiverYou may also apply for a travel award to help with the cost of travel.


ELIGIBILITY

*Applications must be from populations that have been shown to be underrepresented in biomedical research, such as:

  • Underrepresented racial and ethnic groups: African American/Black, Hispanic/Latino, Native American/Alaska Native, or Hawaiian Native/Natives of the U.S. Pacific Islands, or;
  • Individuals with disabilities: defined as those with a physical or mental impairment that substantially limits one or more major life activities, as described in the Americans with Disabilities Act of 1990, or;
  • Individuals from disadvantaged/underserved backgrounds: defined as individuals from an economically disadvantaged background, first generation college graduates, or individuals from challenging social, cultural or educational background, or;
  • Identify as a woman in the biological workforce


REQUIRED EVENT PARTICIPATION

Award recipients are required to participate fully in the following events. Details will be provided with award notification.

Career Workshop and Networking Reception on Wednesday, June 24, 2026.

Poster or Oral Presentation of submitted abstract during meetings, Thursday and Friday, June 25 - 26, 2026.


SUPPORTING DOCUMENTS

  • Inclusivity grant application form submitted by April 3, 2026, 5pm EST.  
  • Abstract - successfully submitted abstract as first/presenting author by March 6, 2026.



INCLUSIVITY GRANT DEADLINE: APRIL 3, 2026, 5:00PM EST


  • All fields are required and must be completed in full for your application to be considered.  Please note availability for the funding is limited.

Submission is now closed.